Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VIR-5500 |
| Trade Name | |
| Synonyms | AMX-500|AMX500|AMX 500|SAR446329|SAR-446329|SAR 446329|VIR5500|VIR 5500 |
| Drug Descriptions |
VIR-5500 (AMX-500) is a dual-masked bispecific T-cell engager that targets FOLH1 (PSMA), which is activated in the tumor microenvironment and potentially induces antitumor activity (J Clin Oncol 44: 16_Suppl, 17). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C222086 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Darolutamide + VIR-5500 | Darolutamide VIR-5500 | 0 | 0 |
| Docetaxel + VIR-5500 | Docetaxel VIR-5500 | 0 | 1 |
| Enzalutamide + VIR-5500 | Enzalutamide VIR-5500 | 0 | 0 |
| VIR-5500 | VIR-5500 | 0 | 1 |